Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Illustrations Gained from a Crosscountry Excursion - 2Virtual National Science Foundation internships aren’t just a pandemic stopgap – they can open up opportunities for more STEM students
- 3What’s the shadowy organisation taking Gaza Palestinians to South Africa?
- 45 Bike Brands for Ordinary Use
- 5Figure out How to Augment the Advantages of a Web-based Degree
- 'Not the moon that I'm used to seeing': Artemis II astronauts describe seeing the far side
- Why this Tennessee special election has the 'whole world' watching
- Reconnecting with an old friend is a story of distance, loss and rediscovery
- Police arrest 18 as anti-war protests spread across Tel Aviv, Haifa, Jerusalem
- Defense Minister Katz moves to extend IDF service to 36 months
- Takeda's AI-crafted psoriasis pill succeeds in late-stage studies
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- Astronauts head home early after medical issue
- See as Your #1: These Low-Sugar Food sources You Ought to Attempt
